Improving Antiplatelet Therapy with a Tailored Approach
Author Information
Author(s): Horst Neubauer, Andreas Kaiser, Heinz Endres, Jan Krüger, Andreas Engelhardt, Sebastian Lask, Fenena Pepinghege, Andreas Kusber, Andreas Mügge
Primary Institution: Cardiovascular Center, Ruhr University Bochum
Hypothesis
A standardized therapeutic algorithm can reduce the prevalence of clopidogrel and aspirin low response.
Conclusion
Following a structured therapy plan based on a 'test and treat' strategy, the prevalence of clopidogrel or aspirin low response can be significantly reduced.
Supporting Evidence
- 30.8% of patients were identified as clopidogrel low responders.
- 19.4% of patients were identified as aspirin low responders.
- After dose adjustments, 94.6% of aspirin low responders were effectively treated.
- The prevalence of clopidogrel low response was reduced by 86.6% with the therapy algorithm.
Takeaway
This study shows that by testing how well patients respond to blood thinners and adjusting their doses, we can help more people avoid heart problems after stenting.
Methodology
Platelet function testing was performed using whole blood aggregometry on patients following coronary stenting, with adjustments made to antiplatelet therapy based on test results.
Potential Biases
Potential biases may arise from the non-randomized design and reliance on specific platelet function tests.
Limitations
The study is observational and non-randomized, and the cut-off values and methods used have limitations.
Participant Demographics
Mean age was 64.3 years, 30.5% were female, and 67.8% had acute coronary syndrome.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website